These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Klinger JR; Warburton RR; Pietras LA; Smithies O; Swift R; Hill NS Am J Physiol; 1999 May; 276(5):L868-74. PubMed ID: 10330043 [TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. Klinger JR; Petit RD; Curtin LA; Warburton RR; Wrenn DS; Steinhelper ME; Field LJ; Hill NS J Appl Physiol (1985); 1993 Jul; 75(1):198-205. PubMed ID: 7690745 [TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension. Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797 [TBL] [Abstract][Full Text] [Related]
6. C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats. Klinger JR; Siddiq FM; Swift RA; Jackson C; Pietras L; Warburton RR; Alia C; Hill NS Am J Physiol; 1998 Oct; 275(4):L645-52. PubMed ID: 9755096 [TBL] [Abstract][Full Text] [Related]
7. Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia. Dempsey EC; Wick MJ; Karoor V; Barr EJ; Tallman DW; Wehling CA; Walchak SJ; Laudi S; Le M; Oka M; Majka S; Cool CD; Fagan KA; Klemm DJ; Hersh LB; Gerard NP; Gerard C; Miller YE Am J Pathol; 2009 Mar; 174(3):782-96. PubMed ID: 19234135 [TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats. Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874 [TBL] [Abstract][Full Text] [Related]
9. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice. Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532 [TBL] [Abstract][Full Text] [Related]
12. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice. Sun M; Ramchandran R; Chen J; Yang Q; Raj JU Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786 [TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia. Thompson JS; Sheedy W; Morice AH Br J Pharmacol; 1994 Dec; 113(4):1121-6. PubMed ID: 7889263 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension. Louzier V; Eddahibi S; Raffestin B; Déprez I; Adam M; Levame M; Eloit M; Adnot S Hum Gene Ther; 2001 Mar; 12(5):503-13. PubMed ID: 11268283 [TBL] [Abstract][Full Text] [Related]
15. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension. Malczyk M; Veith C; Fuchs B; Hofmann K; Storch U; Schermuly RT; Witzenrath M; Ahlbrecht K; Fecher-Trost C; Flockerzi V; Ghofrani HA; Grimminger F; Seeger W; Gudermann T; Dietrich A; Weissmann N Am J Respir Crit Care Med; 2013 Dec; 188(12):1451-9. PubMed ID: 24251695 [TBL] [Abstract][Full Text] [Related]